April 22, 2019 06:16 AM EDT
Pharma

FDA ap­proves the first gener­ic for life-sav­ing opi­oid over­dose treat­ment nalox­one that can be car­ried by un­trained in­di­vid­u­als

Natalie Grover

Reporter

On av­er­age, opi­oids kill more than 130 Amer­i­cans every day. An ef­fec­tive agent to halt or re­verse the ef­fects of an opi­oid over­dose is nalox­one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times